Key result
Statin use in patients with non-alcoholic fatty liver disease is potentially limited by safety concerns, decreased awareness, or a combination of both.
This is an editorial discussing statin use in patients with NAFLD.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mallet et al. (2021) studied this question. Statin use in patients with non-alcoholic fatty liver disease is potentially limited by safety concerns, decreased awareness, or a combination of both.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: